Weaning from mechanical ventilation is difficult in the intensive care unit (ICU). Many controversial questions remain unanswered concerning the predictors of weaning failure. This study investigates patient characteristics and delayed weaning after lung transplantation. Methods: This study retrospectively reviewed the medical records of 17 lung transplantation patients from October 2012 to December 2013. Patients able to be weaned from mechanical ventilation within 8 days after surgery were assigned to an early group (n = 9), and the rest of the patients were assigned to the delayed group (n=8). Patients' intraoperative and postoperative characteristics were collected and analyzed, and conventional weaning predictors, including rapid shallow breathing index (RSBI), were also assessed.
Introduction
Lung transplantation is one of the few feasible treatment options for end-stage lung disease. The first lung transplantation was described in 1963, [1] and it provided decades of survival after decades. [2] Since the first successful case, the number of transplants has continued to increase and the clinical outcomes of lung transplantation continue to improve, as the International Society of Heart and Lung Transplantation reported over 43,000 transplants worldwide, and the associated 5-year survival rate reached 53%. [3] Specifically, in Korea, the first lung transplantation was reported in 1996, and a case series of 13 patients was published in 2006. [4] Following transplantation, the day of extubation is one of the most critical moments in the intensive care unit (ICU) stay.
Early extubation after lung transplantation (within 12 hours) has been frequently reported, [5, 6] but this maneuver should be performed very cautiously in select patients to avoid the serious complications associated with reintubation. The median time to extubation in lung transplantation patients was reported to be approximately 3 days, and the range was between one and 312 hours. [7, 8] According to these reports, most lung transplantation patients undergo mechanical ventilator weaning and extubation while still in the ICU.
When deciding to wean patients from mechanical ventilation (MV), many parameters are considered, including demographic data, perioperative variables and laboratory data such as acceptable gas exchange. MV itself is a major determinant of ICU length of stay (LOS). One prospective study specific to lung surgery reported that preoperative body mass index (BMI) prior to lung volume reduction surgery is a sensitive measure of the patient's nutritional state, and a low BMI correlates to prolonged postoperative MV. [9] In addition to BMI, Lee et al. [10] also published that the median ICU LOS following a single lung transplantation was 5 days, and that pulmonary hypertension and poor immediate postoperative oxygenation (ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen [PaO2/FiO2] of less than 200 mmHg) were good predictors of a prolonged ICU stay. [10] Extubation and weaning from MV performed in a timely manner are critical to ICU management to reduce ICU LOS. To identify risk factors for prolonged MV after unilateral or bilateral lung transplantation, we retrospectively reviewed the medical records of lung transplantation patients who were weaned from MV. We classified and analyzed clinical data that may impact the ability to wean a patient from MV, and organized this data by the preoperative, intraoperative and postoperative periods. Lung mechanics and arterial blood gas analysis (ABGA) during spontaneous breathing trials (SBTs) were investigated, in addition to the well-known weaning predictors of tidal volume (TV), respiratory rate (RR), and rapid shallow breathing index (RSBI). [11] [12] [13] Unless a contraindication to the SBT was present, such as acute rejection or severe bleeding, a spontaneous awakening trial (SAT) and SBT were initiated and evaluated by the multidisciplinary team, which included the surgeon, pulmonologists, anesthesiologists, pharmacists, and nurses. According to some studies, no difference in the percentage of patients passing the SBT or the percentage of patients successfully extubated between T-tube trial and low levels of pressure support (PS), [14, 15] low levels of PS less than 10 cmH2O and T-tube trial were used as SBT in this study. In addition, ABGA was performed 60 minutes after the SBT. If the respiratory pattern, gas exchange, hemodynamic stability and subject comfort were sufficient to pass the SBT, extubation for endotracheally intubated patients or weaning from MV for patients with tracheostomies were done. 
Materials and Methods

Results
A total of 17 patients were enrolled in this study ( Table 1 ).
The median patient age was 52 years. Hospital death occurred in three patients. Etiologies of end-stage lung disease included idiopathic pulmonary fibrosis (9 patients), complications from bone marrow transplantation (3 patients), bronchiectasis (1 patient), usual interstitial pneumonia (1 patient), lymphangioleiomyomatosis (1 patient), dermtatomyositis (1 patient) and chronic obstructive pulmonary disease (COPD) (1 patient).
In this study, the median duration of MV was 8.0 days.
Brochard [16] proposed that patients who are difficult to wean often require up to three SBTs or may take as long as 7 days from the first SBT to achieve successful weaning. In our study, unless there was a contraindication to the SBT, such as acute rejection or severe bleeding, the first SBT was usually initiated the day after surgery. Therefore, patients requiring up to 7 days from the first failed SBT (post-op day 8) to achieve successful weaning were assigned to the delayed group. Thus, the early and delayed groups were defined by a MV duration of 8 days. Nine patients were classified into the early group and eight patients were classified into the delayed group. The first SBT failure rate was similar between the two groups (2/9 vs. 3/8, p = 0.62).
In the early group, patients were older (55 vs. 48 years, p = 0.04) and had less frequent reoperation rates (1/9 vs. 5/8, p = In the early group, the TV just before the SBT was significantly greater (418 vs. 361 ml, p = 0.04) compared to the delayed group, while respiratory rate and RSBI were not significantly different between groups (Table 4 ). PaO2 measurements prior to SBT and 1 hour after SBT were significantly higher in the early group than the delayed group, but PaO2/FiO2 before SBT was not significantly different. However, patients
were given different proportions of oxygen and were given oxygen via different methods after SBT. Therefore, a higher PaO2 before SBT and 1 hour after SBT in the early group does not allow for conclusions to be drawn.
Discussion
The results of the present study show that a low BMI is asso- [17] In addition, Gupta et al. [18] showed that low BMIs less than 18.5 kg/m 2 were associated with increased mortality in 793 surgical ICU patients. Similarly, sarcopenia, based on muscle cross-sectional area at the third lumbar vertebra, was associated with fewer ventilator-free and ICU-free days in elderly patients. [19] An additional retrospective investigation revealed that low BMI was associated with a higher risk of death in acute lung injury patients on MV [20] , and a similar association between low BMI less than 21 and delayed weaning from MV in chronic obstructive lung disease patients has been demonstrated. [21] De la Torre et al. [22] reported that there was no correlation between low BMI and delayed weaning in patients after lung transplantation. However, their study defined low BMI to be less than 20 kg/m 2 , not 18.5 kg/m 2 , which may have blunted their effects. Because in the other study, the Toronto Lung Transplant Group revealed that lower BMI less than 17 was associated with higher risk of 90-day mortality in the patient undergoing lung transplantation. [23] Initially, BMI measurements were introduced to be a marker of the overall nutrition status of the human body. Because adequate nutrition support can improve respiratory muscle contractility and the subsequent ability to expectorate sputum, the duration of MV in critically ill patients could be prolonged in malnourished patients. Therefore, BMI is an important reference index that can be used to estimate MV duration and predict weaning from MV for post-transplantation patients, as the results of this study have indicated.
MV weaning covers the entire process of liberating the patients from mechanical support and from the endotracheal tube.
Weaning from MV starts with a clinical picture suggesting that the patient could tolerate spontaneous breathing. Then, an assessment of readiness to wean, a SBT, and extubation are carried out. [24] Previous studies have reported that the weaning failure rate after a single SBT is between 26 and 42%. [25, 26] If weaning is delayed, patients are exposed to unnecessary discomfort and the risk of complications, including stress ulcer, deep vein thrombosis or pulmonary embolism, and VAP, are increased. For these patients, the increased cost of care due to prolonged hospital and ICU stays can be devastating. The incidence of unplanned extubation ranges from 0.3 to 16%, [27] and almost half of patients who underwent unplanned extubation during the weaning period did not require reintubation. [28] These findings suggest that a significant number of critically ill patients are enduring unnecessary lengths of MV and intubation.
Esteban et al. [29] demonstrated that mortality increases with increasing duration of MV, in part because of the complications of prolonged MV like VAP and airway trauma. [30] Coplin et al. [31] reported that mortality of brain-injured patients was 12%
if there was no delay in extubation, but mortality was increased to 27% in cases of delayed extubation. Moreover, MV has been consistently associated with an increased cost of care of up to US$2,000 per day. [32] Although a relatively small percentage (6%) of ventilated patients experience prolonged MV, these patients consume 37% of ICU resources. [33] Additionally, failure to extubate is associated with high mortality and morbidity by inducing deleterious effects such as aspiration, atelectasis, and pneumonia. [34] Patients undergoing lung transplantation should be cautiously weaned from MV in a timely manner. Most lung transplantation patients are physically debilitated because transplantation tends to be the last treatment option in end-stage lung disease. They usually suffer from long-term malnutrition and sarcopenia, lack of physical activity due to oxygenation failure, and cardiac comorbidities such as right heart failure.
In the literature, a limited number of predictors for ventilator weaning or extubation failure have been suggested. [11] [12] [13] One study reported that the immediate postoperative PaO2 to FiO2 ratio, a history of preexisting pulmonary hypertension, and the pulmonary blood flow distribution were good predictors of the ICU length of stay following single lung transplantation. [10] In addition to these predictors, our study suggests that preoperative BMI and larger TVs before the SBT may be reasonable predictors of weaning in lung transplantation patients. In previous literature, TV was not commonly highlighted as a predictor of delayed weaning or weaning failure. However, RSBI, which was noticed because of its high predictive value, [12] showed some trends, but the small study population may explain why RSBI failed to be a significant predictor of weaning success.
Because the RR was similar between the two groups during the SBTs, RSBI was not statistically significant. The patients with end-stage lung disease had long-term exposure to hypoxia and hypercapnia, so their respiratory drive was decreased. Also, their postoperative pain was controlled with high-dose opioids, specifically remifentanil via intravenous infusion, which may contribute to the patients breathing more deeply and slowly after lung transplantation.
In this study, older age was associated with early weaning.
When we compared the younger age group (< 53 years) to the older group, the younger group also had a lower BMI. One thought is that end-stage lung disease rapidly wastes the metabolic reserve in younger patients. Total energy expenditure, which includes resting energy expenditure, is known to decrease with the aging process. [35] Therefore, it is possible that elderly patients are more resistant to malnutrition because weight-adjusted energy expenditure is lower in the elderly. [36] Prolonged MV is associated with VAP. As demonstrated in COPD patients, higher BMIs could be associated with early weaning from MV, [21] possibly due to improved immunity. Therefore, the relationship between BMI and VAP warrants further investigation.
Compared to other studies, the duration of MV in this study was longer, while weaning failure after the first successful SBT occurred in only two patients. These results suggest that there is room for a faster weaning process in our practice. In addition, the limited number of cases in this study requires further analysis of the variables we chose to study. The small number of the patients in this study (n = 17) is one reason why the predictive power was not analyzed by a receiver operating characteristic curve.
In the present study, we demonstrated MV more than 8 days after unilateral or bilateral lung transplantation to be associated with lower BMI and smaller tidal volume before SBT. Notably, postoperative comorbidities associated with prolonged MV were found to be ECMO use and VAP.
